Regulation 2 Amendments to the Branded Health Service Medicines (Costs) Regulations 2018

(1)

Regulation 3 (payment scheme) of the Branded Health Service Medicines (Costs) Regulations 2018^f1 is amended as follows.

(2)

In paragraph (1), for the table substitute the following table—

“

Table

Applicable Period Newer presentation payment percentage Older presentation payment percentage

1st July 2026 to the end of 2026 16.5% 11%
1st January 2027 to the end of 2027 and any subsequent calendar year 16.5% 10.9%

”.

Applicable Period	Newer presentation payment percentage	Older presentation payment percentage
1st July 2026 to the end of 2026	16.5%	11%
1st January 2027 to the end of 2027 and any subsequent calendar year	16.5%	10.9%

(3)

In paragraph (1AB)—

(a)

for “1st July 2025 and ending at the end of 2025”, substitute “1st July 2026 and ending at the end of 2026”; and

(b)

for “31.3% and not 23.4%”, substitute “8.7% and not 16.5%”.

(4)

In paragraph (1AC)—

(a)

for “1st July 2025 and ending at the end of 2025”, substitute “1st July 2026 and ending at the end of 2026”;

(b)

in sub-paragraph (a), for “1st January 2025 and ending at the end of 30 June 2025”, substitute “1st January 2026 and ending at the end of 30 June 2026”; and

(c)

in sub-paragraph (b), for “15.5%”, substitute “24.3%”.

Annotations

Footnotes

f1: S.I. 2018/345. Relevant amending instruments are S.I. 2018/1255, 2020/258, 2022/593, 2023/239, 2023/1307, 2024/1277 and 2025/667.